In liver cancer, DDX3X affects the levels of a subset of tumour-suppressive miRNAs by reducing DNMT3A (DNA methyltransferase 3A) binding and hypermethylation on the promoter regions of these miRNAs [66]. This evidence concerns the gene DDX3X and neoplasm.